Dalton Bioanalytics

10:15 AM - 10:30 AM (EDT), Wednesday, October 23, 2019 ・ 2nd Floor
Dalton Bioanalytics is a data science company spinning out of UCLA.
The expense of blood testing is limiting our access to health information, indirectly harming individuals and also blocking innovation in biomedicine. We are solving this by digitizing blood to cut the costs of multi-biomarker measurement by 80% using LC-MS technology. We aim to make comprehensive health screening and diagnosis affordable, unlocking the future of preventative and precision medicine.

Rather than measuring after each blood analyte individually, we use our novel LC-MS based technology to digitize the entire biochemical blood signature including proteins, lipids, electrolytes, and small molecules. Numerous blood test values can then be computationally extracted from this data, eliminating the costs of additional testing.
Company Type:
Company Website:
Company HQ State:
California
Company HQ Country:
United States
Year Founded:
2019
Main Therapeutic Focus:
Lead Product in Development:
Blood analysis using LC-MS
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided